Circulating tumour cells detected by a novel adenovirus-mediated system may be a potent therapeutic marker in gynaecological cancers

M. Takakura, S. Kyo, M. Nakamura, Y. Maida, Y. Mizumoto, Y. Bono, X. Zhang, Y. Hashimoto, Y. Urata, Toshiyoshi Fujiwara, M. Inoue

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

Background: Recently developed detection system for circulating tumour cells (CTCs) using a telomerase-specific replicative adenovirus generated nonspecific green fluorescent protein (GFP) signals because of the co-presence of white blood cells (WBCs) nonspecifically infected by viruses. Here, we established a unique detection system for CTCs that completely excludes nonspecific signals.Methods:Blood obtained from the patients was subjected to haemolytic processes to eliminate red blood cells. The cell pellets were then infected with OBP-401, fixed, incubated with fluorescence-labelled anti-CD45 antibody to mark white blood WBCs, and examined on slides under a microscope.Results:Preparatory experiments with cancer cells artificially added to healthy donor samples confirmed that CD45 labelling could distinguish GFP-positive cancer cells from WBCs. In 53 patients with gynaecological cancers, CTCs were detected in 21 patients (39.6%) when CD45-positive cells were excluded as WBCs among GFP-positive cells. No CTCs were detected in samples from healthy volunteers. There was no significant correlation between CTC counts and known clinicopathological factors. The CTCs rapidly vanished after surgery or chemotherapy in most patients whose treatments were effective. In contrast, the persistence of CTCs even after treatments was tightly associated with poor response to the treatments (P

Original languageEnglish
Pages (from-to)448-454
Number of pages7
JournalBritish Journal of Cancer
Volume107
Issue number3
DOIs
Publication statusPublished - Jul 24 2012

Fingerprint

Circulating Neoplastic Cells
Adenoviridae
Leukocytes
Green Fluorescent Proteins
Neoplasms
Therapeutics
Telomerase
Anti-Idiotypic Antibodies
Healthy Volunteers
Cell Count
Erythrocytes
Fluorescence
Tissue Donors
Viruses
Drug Therapy

Keywords

  • adenovirus
  • circulating tumour cells
  • GFP
  • gynaecological cancers
  • telomerase

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Circulating tumour cells detected by a novel adenovirus-mediated system may be a potent therapeutic marker in gynaecological cancers. / Takakura, M.; Kyo, S.; Nakamura, M.; Maida, Y.; Mizumoto, Y.; Bono, Y.; Zhang, X.; Hashimoto, Y.; Urata, Y.; Fujiwara, Toshiyoshi; Inoue, M.

In: British Journal of Cancer, Vol. 107, No. 3, 24.07.2012, p. 448-454.

Research output: Contribution to journalArticle

Takakura, M, Kyo, S, Nakamura, M, Maida, Y, Mizumoto, Y, Bono, Y, Zhang, X, Hashimoto, Y, Urata, Y, Fujiwara, T & Inoue, M 2012, 'Circulating tumour cells detected by a novel adenovirus-mediated system may be a potent therapeutic marker in gynaecological cancers', British Journal of Cancer, vol. 107, no. 3, pp. 448-454. https://doi.org/10.1038/bjc.2012.276
Takakura, M. ; Kyo, S. ; Nakamura, M. ; Maida, Y. ; Mizumoto, Y. ; Bono, Y. ; Zhang, X. ; Hashimoto, Y. ; Urata, Y. ; Fujiwara, Toshiyoshi ; Inoue, M. / Circulating tumour cells detected by a novel adenovirus-mediated system may be a potent therapeutic marker in gynaecological cancers. In: British Journal of Cancer. 2012 ; Vol. 107, No. 3. pp. 448-454.
@article{bc92726188fb4355a3d7e5ed528b8790,
title = "Circulating tumour cells detected by a novel adenovirus-mediated system may be a potent therapeutic marker in gynaecological cancers",
abstract = "Background: Recently developed detection system for circulating tumour cells (CTCs) using a telomerase-specific replicative adenovirus generated nonspecific green fluorescent protein (GFP) signals because of the co-presence of white blood cells (WBCs) nonspecifically infected by viruses. Here, we established a unique detection system for CTCs that completely excludes nonspecific signals.Methods:Blood obtained from the patients was subjected to haemolytic processes to eliminate red blood cells. The cell pellets were then infected with OBP-401, fixed, incubated with fluorescence-labelled anti-CD45 antibody to mark white blood WBCs, and examined on slides under a microscope.Results:Preparatory experiments with cancer cells artificially added to healthy donor samples confirmed that CD45 labelling could distinguish GFP-positive cancer cells from WBCs. In 53 patients with gynaecological cancers, CTCs were detected in 21 patients (39.6{\%}) when CD45-positive cells were excluded as WBCs among GFP-positive cells. No CTCs were detected in samples from healthy volunteers. There was no significant correlation between CTC counts and known clinicopathological factors. The CTCs rapidly vanished after surgery or chemotherapy in most patients whose treatments were effective. In contrast, the persistence of CTCs even after treatments was tightly associated with poor response to the treatments (P",
keywords = "adenovirus, circulating tumour cells, GFP, gynaecological cancers, telomerase",
author = "M. Takakura and S. Kyo and M. Nakamura and Y. Maida and Y. Mizumoto and Y. Bono and X. Zhang and Y. Hashimoto and Y. Urata and Toshiyoshi Fujiwara and M. Inoue",
year = "2012",
month = "7",
day = "24",
doi = "10.1038/bjc.2012.276",
language = "English",
volume = "107",
pages = "448--454",
journal = "British Journal of Cancer",
issn = "0007-0920",
publisher = "Nature Publishing Group",
number = "3",

}

TY - JOUR

T1 - Circulating tumour cells detected by a novel adenovirus-mediated system may be a potent therapeutic marker in gynaecological cancers

AU - Takakura, M.

AU - Kyo, S.

AU - Nakamura, M.

AU - Maida, Y.

AU - Mizumoto, Y.

AU - Bono, Y.

AU - Zhang, X.

AU - Hashimoto, Y.

AU - Urata, Y.

AU - Fujiwara, Toshiyoshi

AU - Inoue, M.

PY - 2012/7/24

Y1 - 2012/7/24

N2 - Background: Recently developed detection system for circulating tumour cells (CTCs) using a telomerase-specific replicative adenovirus generated nonspecific green fluorescent protein (GFP) signals because of the co-presence of white blood cells (WBCs) nonspecifically infected by viruses. Here, we established a unique detection system for CTCs that completely excludes nonspecific signals.Methods:Blood obtained from the patients was subjected to haemolytic processes to eliminate red blood cells. The cell pellets were then infected with OBP-401, fixed, incubated with fluorescence-labelled anti-CD45 antibody to mark white blood WBCs, and examined on slides under a microscope.Results:Preparatory experiments with cancer cells artificially added to healthy donor samples confirmed that CD45 labelling could distinguish GFP-positive cancer cells from WBCs. In 53 patients with gynaecological cancers, CTCs were detected in 21 patients (39.6%) when CD45-positive cells were excluded as WBCs among GFP-positive cells. No CTCs were detected in samples from healthy volunteers. There was no significant correlation between CTC counts and known clinicopathological factors. The CTCs rapidly vanished after surgery or chemotherapy in most patients whose treatments were effective. In contrast, the persistence of CTCs even after treatments was tightly associated with poor response to the treatments (P

AB - Background: Recently developed detection system for circulating tumour cells (CTCs) using a telomerase-specific replicative adenovirus generated nonspecific green fluorescent protein (GFP) signals because of the co-presence of white blood cells (WBCs) nonspecifically infected by viruses. Here, we established a unique detection system for CTCs that completely excludes nonspecific signals.Methods:Blood obtained from the patients was subjected to haemolytic processes to eliminate red blood cells. The cell pellets were then infected with OBP-401, fixed, incubated with fluorescence-labelled anti-CD45 antibody to mark white blood WBCs, and examined on slides under a microscope.Results:Preparatory experiments with cancer cells artificially added to healthy donor samples confirmed that CD45 labelling could distinguish GFP-positive cancer cells from WBCs. In 53 patients with gynaecological cancers, CTCs were detected in 21 patients (39.6%) when CD45-positive cells were excluded as WBCs among GFP-positive cells. No CTCs were detected in samples from healthy volunteers. There was no significant correlation between CTC counts and known clinicopathological factors. The CTCs rapidly vanished after surgery or chemotherapy in most patients whose treatments were effective. In contrast, the persistence of CTCs even after treatments was tightly associated with poor response to the treatments (P

KW - adenovirus

KW - circulating tumour cells

KW - GFP

KW - gynaecological cancers

KW - telomerase

UR - http://www.scopus.com/inward/record.url?scp=84864357206&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84864357206&partnerID=8YFLogxK

U2 - 10.1038/bjc.2012.276

DO - 10.1038/bjc.2012.276

M3 - Article

VL - 107

SP - 448

EP - 454

JO - British Journal of Cancer

JF - British Journal of Cancer

SN - 0007-0920

IS - 3

ER -